What is the most accurate statement regarding Disseminated Intravascular Coagulation (DIC)?
What is characteristically found in the bone marrow in lead poisoning?
Which mediastinal tumor is most likely associated with red blood cell aplasia?
All of the following are true regarding the findings of peripheral smear in vitamin B12 deficiency except?
Which of the following lymph nodes are commonly affected in non-Hodgkin's Lymphoma, except?
A 25-year-old female presents with palpable lumps in the axilla and supra-clavicular region. Following clinical examination and diagnostic procedures including X-ray, USG-guided biopsy, and HPE, a diagnosis was established. Flow cytometry revealed CD15 and CD30 positivity. The patient was initiated on chemotherapy and subsequently developed skin lesions. Which of the following chemotherapeutic agents is most likely responsible for these skin manifestations?
What is the concentration of Hb A2 in thalassemia trait?
A 28-year-old female presents with recurrent abortions and pain in the calves. She is most likely suffering from a deficiency of which of the following?
What happens to the haptoglobin level in hemolytic anemia?
All of the following precipitate sickling of HBS except?
Explanation: **Explanation:** Disseminated Intravascular Coagulation (DIC) is a complex thrombohemorrhagic disorder characterized by the systemic activation of the coagulation cascade, leading to widespread microvascular thrombosis and subsequent consumption of clotting factors and platelets [1]. **Why Option D is Correct:** The hallmark of DIC is the simultaneous activation of coagulation and fibrinolysis. As the body attempts to break down the widespread fibrin clots, plasmin cleaves cross-linked fibrin. This process releases **D-dimers** (specific degradation products of cross-linked fibrin) into the circulation [1], [2]. Elevated D-dimer levels are the most sensitive laboratory indicator for DIC. **Analysis of Incorrect Options:** * **Option A:** While treating the underlying cause is the cornerstone of management, it does not always lead to "complete resolution," especially if end-organ damage (due to ischemia or hemorrhage) has already occurred [2]. * **Option B:** In DIC, fibrinogen is **consumed** during the formation of widespread clots [1]. Therefore, serum fibrinogen levels are typically **decreased**, not increased [2]. * **Option C:** DIC is a dynamic process. In early or "compensated" stages, standard parameters (PT, APTT, Platelets) may initially appear near normal. A single set of normal parameters does not definitively exclude an evolving DIC [2]. **NEET-PG High-Yield Pearls:** * **Blood Smear:** Characterized by **Schistocytes** (fragmented RBCs) due to microangiopathic hemolytic anemia (MAHA) [2]. * **Common Triggers:** Sepsis (Gram-negative), Obstetric complications (Abruptio placentae), and Acute Promyelocytic Leukemia (M3). * **Lab Profile:** ↑ PT/APTT, ↓ Platelets, ↓ Fibrinogen, and ↑ FDPs/D-dimer [1], [2]. * **Best Screening Test:** Platelet count and PT. * **Most Specific Test:** D-dimer. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 151-152. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 625-626.
Explanation: **Explanation:** Lead poisoning (Plumbism) interferes with the biosynthesis of heme by inhibiting two key enzymes: **delta-aminolevulinic acid dehydratase (ALAD)** and **Ferrochelatase** [1]. The inhibition of Ferrochelatase prevents the incorporation of iron into the protoporphyrin ring. Consequently, iron accumulates within the mitochondria of developing erythroblasts in the bone marrow. When these cells are stained with **Prussian Blue (Perls' stain)**, the iron-laden mitochondria appear as a necklace-like ring around the nucleus, termed **Ringed Sideroblasts** (or Siderocytes in mature forms). **Analysis of Options:** * **A. Ringed siderocytes (Correct):** These are the hallmark of sideroblastic anemias, which can be hereditary or acquired (e.g., lead poisoning, alcohol, or MDS). * **B. Giant metamyelocytes:** These are characteristic of **Megaloblastic Anemia** (Vitamin B12 or Folate deficiency) due to impaired DNA synthesis and nuclear-cytoplasmic dyssynchrony. * **C. Dwarf megakaryocytes (Micromegakaryocytes):** These are small, mononuclear megakaryocytes typically seen in **Myelodysplastic Syndromes (MDS)** or Chronic Myeloid Leukemia (CML). * **D. Fibrotic changes:** Extensive marrow fibrosis is characteristic of **Primary Myelofibrosis** or late-stage "spent phase" polycythemia vera. **High-Yield Clinical Pearls for NEET-PG:** * **Peripheral Smear:** Look for **Coarse Basophilic Stippling** (due to inhibition of 5'-nucleotidase, leading to ribosomal RNA degradation). * **X-ray:** "Lead lines" at the metaphyses of growing long bones in children [1]. * **Gums:** "Burtonian lines" (bluish-purple pigmentation at the gingival margin). * **Treatment:** Chelation therapy with **Succimer** (oral, first-line in kids) or **CaNa₂EDTA**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 418-419.
Explanation: **Explanation:** **Thymoma** is the correct answer because it is the most common mediastinal tumor associated with **Pure Red Cell Aplasia (PRCA)** [4]. Approximately 5–15% of patients with thymoma develop PRCA, and conversely, about 30–50% of patients with PRCA are found to have a thymoma [1]. The underlying mechanism is **autoimmune-mediated**, where T-cells or IgG antibodies (produced due to immune dysregulation within the thymus) target erythroid progenitor cells in the bone marrow, leading to a selective cessation of red blood cell production [2]. **Analysis of Incorrect Options:** * **Hodgkin’s Disease:** While it is a common anterior mediastinal mass, it is more typically associated with paraneoplastic syndromes like nephrotic syndrome or alcohol-induced pain, rather than PRCA. * **Neuroblastoma:** This is a posterior mediastinal tumor in children. It is associated with opsoclonus-myoclonus syndrome or catecholamine excess, not selective erythroid aplasia. * **Parathyroid Adenoma:** While ectopic parathyroid tissue can be found in the mediastinum, it presents with primary hyperparathyroidism (hypercalcemia), not hematological abnormalities. **High-Yield Clinical Pearls for NEET-PG:** * **Thymoma Associations:** Remember the "Triple Threat": **Myasthenia Gravis** (most common, 30-45%), **Pure Red Cell Aplasia**, and **Hypogammaglobulinemia** (Good’s Syndrome) [4]. * **PRCA Diagnosis:** Bone marrow biopsy shows a near-total absence of erythroid precursors, but normal granulopoiesis and megakaryopoiesis [3]. * **Management:** Surgical resection of the thymoma can lead to remission of PRCA in about 25–30% of cases. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 595-596. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 662. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 662-663. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 634-635.
Explanation: **Explanation:** Vitamin B12 (Cobalamin) deficiency leads to **Megaloblastic Anemia**, characterized by impaired DNA synthesis while RNA synthesis and cytoplasmic maturation remain unaffected [1]. This "nuclear-cytoplasmic asynchrony" is the hallmark of the condition [1], [3]. **Why Option D is the Correct Answer:** In Vitamin B12 deficiency, the red blood cells are **Macrocytic** (Mean Corpuscular Volume/MCV > 100 fL), not microcytic. Due to defective DNA synthesis, the erythroblasts fail to undergo the normal number of cell divisions, resulting in larger-than-normal cells (Macro-ovalocytes) [3]. Microcytic red cells are typically seen in Iron Deficiency Anemia or Thalassemia. **Analysis of Other Options:** * **A. Hypercellular marrow:** Although the peripheral blood shows cytopenia, the bone marrow is characteristically hypercellular due to an accumulation of megaloblasts [1], [3]. However, because of **ineffective erythropoiesis**, these cells die within the marrow (intramedullary hemolysis). * **B. Poikilocytosis:** Peripheral smears show significant variation in cell shape (poikilocytosis), including the classic large, egg-shaped **macro-ovalocytes** and occasional schistocytes [1]. * **C. Hypersegmented neutrophils:** This is often the **earliest sign** of megaloblastic anemia [2]. It is defined as the presence of neutrophils with $\geq$ 6 lobes or more than 5% of neutrophils having 5 lobes [2]. **NEET-PG High-Yield Pearls:** * **Pancytopenia:** Severe B12 deficiency can cause a reduction in all three cell lines (RBCs, WBCs, and Platelets). * **Biochemical Markers:** Elevated levels of **Methylmalonic Acid (MMA)** and **Homocysteine** are diagnostic (Note: In Folate deficiency, only Homocysteine is elevated). * **Neurological Findings:** Subacute Combined Degeneration (SCD) of the spinal cord is unique to B12 deficiency and does not occur in pure Folate deficiency. * **Howell-Jolly Bodies:** These nuclear remnants may be seen in the peripheral smear due to dysfunctional erythropoiesis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 593-594. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 654. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 654-655.
Explanation: **Explanation:** The distinction between **Hodgkin Lymphoma (HL)** and **Non-Hodgkin Lymphoma (NHL)** regarding nodal involvement is a high-yield concept in hematopathology. [3] **Why Mediastinal Lymph Nodes is the correct answer:** While NHL can involve any lymphoid tissue, **mediastinal (hilar) lymphadenopathy** is a classic hallmark of **Hodgkin Lymphoma** (specifically the Nodular Sclerosis subtype). [1] In contrast, mediastinal involvement is relatively **uncommon** in most types of NHL, with the notable exception of Lymphoblastic Lymphoma and Primary Mediastinal B-cell Lymphoma. [4] Therefore, compared to the other options, it is the "least common" or "except" site for typical NHL presentations. **Analysis of Incorrect Options:** * **Epitrochlear lymph nodes:** Involvement of "unusual" or non-contiguous peripheral nodes (like epitrochlear or popliteal) is highly suggestive of **NHL**. HL typically spreads in an orderly, contiguous fashion and rarely involves these sites. [2] * **Peripheral lymph nodes:** NHL frequently presents with diffuse, painless, and non-contiguous peripheral lymphadenopathy (cervical, axillary, inguinal). [3] * **Inner Waldeyer ring:** Involvement of extranodal sites and the Waldeyer ring (tonsils, base of tongue, nasopharynx) is a characteristic feature of **NHL**. HL almost never involves the Waldeyer ring. [3] **NEET-PG High-Yield Pearls:** 1. **Spread:** HL spreads **contiguously** (predictable); NHL spreads **hematogenously/non-contiguously** (unpredictable). [2] 2. **Extranodal Involvement:** Common in NHL (GI tract is the most common site); rare in HL. [3] 3. **Waldeyer Ring & Epitrochlear Nodes:** If involved, think **NHL**. 4. **Mediastinal Mass:** If present in a young female with pruritus, think **Nodular Sclerosis HL**. [1] **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 558-559. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 557-558. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 614-616. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 560-561.
Explanation: **Explanation:** **Diagnosis and Rationale:** The clinical presentation of axillary and supraclavicular lymphadenopathy in a young female, combined with flow cytometry showing **CD15 and CD30 positivity**, is pathognomonic for **Hodgkin Lymphoma (HL)** [1]. The standard first-line treatment for HL is the **ABVD regimen** (Adriamycin, Bleomycin, Vinblastine, and Dacarbazine). Among these agents, **Bleomycin** is notorious for causing specific cutaneous side effects. **Why Bleomycin is Correct:** Bleomycin-induced skin toxicity occurs because the skin (and lungs) lacks the enzyme **bleomycin hydrolase**, which inactivates the drug. The most characteristic skin manifestation is **Flagellate Erythema** (linear, whip-like hyperpigmented streaks), though it can also cause hyperkeratosis and ulceration. **Analysis of Incorrect Options:** * **A. Daunorubicin:** An anthracycline primarily used in acute leukemias (AML/ALL). While it causes alopecia and cardiotoxicity, it is not part of the standard ABVD regimen for HL (which uses Doxorubicin/Adriamycin). * **C. Capecitabine:** An oral prodrug of 5-FU used mainly in GI and breast cancers. Its classic skin toxicity is **Hand-Foot Syndrome** (palmar-plantar erythrodysesthesia), not flagellate lesions. * **D. Cyclophosphamide:** An alkylating agent used in the CHOP regimen (for Non-Hodgkin Lymphoma). Its most high-yield side effect is **hemorrhagic cystitis** due to acrolein accumulation [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Bleomycin:** Associated with pulmonary fibrosis (restrictive lung disease) and flagellate dermatitis. * **CD30/CD15:** Markers for Reed-Sternberg cells in Classical Hodgkin Lymphoma. * **ABVD vs. CHOP:** Remember ABVD is for Hodgkin, while CHOP is for Non-Hodgkin Lymphoma. * **Acrolein:** The metabolite of Cyclophosphamide prevented by **MESNA**. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 614-620.
Explanation: **Explanation:** In **$\beta$-thalassemia trait** (minor), there is a partial deficiency in the production of $\beta$-globin chains. To compensate for this deficit, the body increases the production of alternative hemoglobin types that do not require $\beta$-chains. 1. **Why "Slightly Increased" is correct:** In $\beta$-thalassemia trait, the excess $\alpha$-chains pair with $\delta$-chains to form **Hb A2 ($\alpha_2\delta_2$)**. In a healthy adult, Hb A2 is typically <3%. In $\beta$-thalassemia trait, it characteristically rises to **3.5% – 7%**. While this is a diagnostic increase, it is medically classified as "slight" compared to the massive shifts seen in other hemoglobinopathies. 2. **Analysis of Incorrect Options:** * **Normal:** A normal Hb A2 level (2-3%) usually rules out $\beta$-thalassemia trait (except in rare cases of co-existing iron deficiency). * **Increased/Markedly Increased:** These terms are imprecise or misleading. "Markedly increased" would describe HbF levels in $\beta$-thalassemia major (often >90%). In the context of standardized exams like NEET-PG, the specific elevation of Hb A2 in trait is classically described as "slight." **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Hb electrophoresis showing Hb A2 >3.5% is the diagnostic hallmark of $\beta$-thalassemia trait. * **Mentzer Index:** (MCV/RBC count) <13 suggests Thalassemia; >13 suggests Iron Deficiency Anemia (IDA). * **The IDA Trap:** Concomitant iron deficiency can mask $\beta$-thalassemia trait by lowering Hb A2 levels into the normal range. Always correct iron stores before testing. * **Peripheral Smear:** Shows microcytic hypochromic anemia with **target cells** and basophilic stippling [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591.
Explanation: **Explanation:** The clinical presentation of **recurrent abortions** (suggestive of placental infarction) and **calf pain** (suggestive of Deep Vein Thrombosis/DVT) in a young female points toward a **hypercoagulable state** or hereditary thrombophilia [1]. **Why Protein C is the correct answer:** Protein C is a potent natural anticoagulant. When activated by thrombin (via thrombomodulin), **Activated Protein C (APC)**, along with its cofactor Protein S, proteolytically inactivates **Factors Va and VIIIa** [1]. A deficiency in Protein C leads to an inability to inhibit the coagulation cascade, resulting in unregulated thrombin generation and a high risk for venous thromboembolism (VTE) and obstetric complications like recurrent pregnancy loss. **Analysis of Incorrect Options:** * **B. Thrombin (Factor IIa):** Thrombin is a procoagulant that converts fibrinogen to fibrin. A deficiency would lead to a **bleeding diathesis**, not thrombosis. * **C. Factor XIII:** This factor stabilizes the fibrin clot. Deficiency leads to poor wound healing and delayed **bleeding** (e.g., umbilical cord stump bleeding in neonates). * **D. Plasmin:** Plasmin is the primary enzyme responsible for fibrinolysis (breaking down clots). While a deficiency could theoretically cause thrombosis, it is an extremely rare clinical entity compared to Protein C deficiency. **NEET-PG High-Yield Pearls:** 1. **Warfarin-Induced Skin Necrosis:** Patients with Protein C deficiency are at high risk for skin necrosis when starting Warfarin, due to the rapid decline of Protein C levels before the depletion of procoagulant factors (II, VII, IX, X). 2. **Most Common Cause:** While Protein C deficiency is a classic exam answer, **Factor V Leiden** (APC resistance) is the most common inherited cause of hypercoagulability in Caucasians [1]. 3. **Differential Diagnosis:** Always consider **Antiphospholipid Antibody Syndrome (APS)** in young females with recurrent abortions and thrombosis [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, pp. 133-134. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 626-627.
Explanation: **Explanation:** **Why the correct answer is right:** Haptoglobin is a plasma glycoprotein synthesized by the liver whose primary function is to bind free hemoglobin (Hb) released into the circulation. In **hemolytic anemia**, red blood cells are destroyed, releasing free hemoglobin into the plasma. Haptoglobin binds to this free hemoglobin to form a **Haptoglobin-Hemoglobin (Hp-Hb) complex**. This complex is rapidly cleared from the circulation by the reticuloendothelial system (specifically by CD163 receptors on macrophages) [1]. Because the rate of haptoglobin consumption and clearance exceeds the liver's synthetic capacity, the serum levels of free haptoglobin **decrease** significantly [1]. This is a hallmark laboratory finding of intravascular hemolysis. **Why incorrect options are wrong:** * **Option A:** Haptoglobin levels do not increase in hemolysis because it is being actively consumed to clear free hemoglobin. (Note: Haptoglobin is an acute-phase reactant and may increase in inflammation, but not due to hemolysis). * **Option C:** Levels cannot remain the same because the binding and subsequent clearance of the Hp-Hb complex is a rapid, stoichiometric process. * **Option D:** While chronicity affects many parameters, a decrease in haptoglobin is a consistent finding in both acute and chronic hemolytic states as long as hemolysis is active. **NEET-PG High-Yield Pearls:** * **Most Sensitive Marker:** A low serum haptoglobin level is considered the most sensitive biochemical marker for **intravascular hemolysis** [1]. * **Intravascular vs. Extravascular:** While haptoglobin decreases most dramatically in intravascular hemolysis, it can also decrease in severe extravascular hemolysis as some hemoglobin inevitably escapes into the plasma. * **Other Markers:** In hemolytic anemia, look for increased **LDH**, increased **indirect bilirubin**, and increased **reticulocyte count** [1]. * **False Normal:** Since haptoglobin is an **acute-phase reactant**, levels may appear "normal" if the patient has concurrent inflammation or infection, even if hemolysis is present. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 639-640.
Explanation: **Explanation:** The fundamental pathophysiology of Sickle Cell Disease (SCD) involves the polymerization of deoxygenated Hemoglobin S (HbS). When HbS is deoxygenated, it undergoes a conformational change that allows it to form long, needle-like polymers, distorting the red blood cell into a "sickle" shape [2], [3]. **Why Increased pH is the Correct Answer:** Sickling is highly sensitive to pH levels. **Acidosis (decreased pH)** reduces the oxygen affinity of hemoglobin (shifting the oxygen dissociation curve to the right), which promotes the formation of deoxy-HbS and triggers sickling. Conversely, **Increased pH (Alkalosis)** increases hemoglobin's affinity for oxygen, keeping HbS in its oxygenated state and thereby **inhibiting** or preventing sickling. **Analysis of Incorrect Options:** * **Dehydration:** Increases the Mean Corpuscular Hemoglobin Concentration (MCHC). A higher concentration of HbS within the cell significantly facilitates faster polymerization and sickling [2]. * **Hypoxia:** Low oxygen tension is the primary trigger for sickling [1]. It promotes the formation of the "T" (Tense) state of hemoglobin, which is the state susceptible to polymerization [3]. * **Infections:** These precipitate sickling through multiple mechanisms, including inflammation-induced acidosis, fever (increased temperature promotes sickling), and dehydration [4]. **High-Yield Clinical Pearls for NEET-PG:** * **The Rate-Limiting Step:** The "delay time" for HbS polymerization is extremely sensitive to HbS concentration. Even a small decrease in cell volume (dehydration) drastically increases sickling [2]. * **Protective Factors:** HbF (Fetal Hemoglobin) inhibits sickling; this is why hydroxyurea is used in treatment (it increases HbF levels). * **Organ Damage:** The earliest clinical manifestation is often **Dactylitis** (Hand-foot syndrome) in infants [4]. The most common cause of death in adults is **Acute Chest Syndrome** [1], [4]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 599-600. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 643-644. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 598-599. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 645-646.
Anemias: Classification and Approach
Practice Questions
Hemolytic Anemias
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Myelodysplastic Syndromes
Practice Questions
Acute Leukemias
Practice Questions
Chronic Leukemias
Practice Questions
Lymphomas and Lymphoid Neoplasms
Practice Questions
Plasma Cell Disorders
Practice Questions
Bleeding Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free